Predict Payer Access
Before launch, market access teams are eager to know how payers will respond to their brand. MMIT’s Smart Access takes the guesswork out of forecasting, replacing subjective analog selection with AI-ranked, data-backed comparators. Smart Access translates years of MMIT’s payer intelligence — across hundreds of indications and therapies — into accurate expectations for your brand.
Leverage AI to select ideal analogs for your brand based on weighted parameters like TA, launch type, administration route and competition.
Establish forward-looking coverage curves with predicted coverage and restriction behavior at 3, 6, 9, and 12 months post-launch.
Set quarterly access targets for payer outreach with automatic payer segmentation by restrictiveness, review timing, and speed of coverage.